Over the last decade, advances in 3D printing have unlocked new possibilities for bioengineers to build heart tissues and structures.
Teva and US government discuss settling kickback lawsuit over Copaxone
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS